ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Dai Nippon Pharmaceutical (PK)

Dai Nippon Pharmaceutical (PK) (DNPUF)

9,41
0,00
( 0,00% )
Aktualisiert: 15:50:25

Dai Nippon Pharmaceutical (PK) (DNPUF) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
9,41
( - )
Gebot
8,98
Fragen
9,98
Volumen
-
0,00 Tagesbereich 0,00
6,34 52-Wochen-Bereich 19,20
Marktkapitalisierung
Handelsende
9,41
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 9.699.639
Ausgegebene Aktien
448.593.449
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
5,27
Gewinn pro Aktie (EPS)
268,99
Erlöse (LTM)
453,29B
Nettogewinn (LTM)
106,87B

Über Dai Nippon Pharmaceutical (PK)

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and p... Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Hauptsitz
Osaka, Japan
Gegründet
1897
Dai Nippon Pharmaceutical (PK) is listed in the Healthcare sector of the OTC Markets with ticker DNPUF. The last closing price for Dai Nippon Pharmaceutical (PK) was US$9,41. Over the last year, Dai Nippon Pharmaceutical (PK) shares have traded in a share price range of US$ 6,34 to US$ 19,20.

Dai Nippon Pharmaceutical (PK) currently has 448.593.449 shares in issue. The market capitalisation of Dai Nippon Pharmaceutical (PK) is US$4,22 billion. Dai Nippon Pharmaceutical (PK) has a price to earnings ratio (PE ratio) of 5.27.

DNPUF Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.5366.04011719638.8749.418.8749009.11222222CS
4-0.74-7.2906403940910.1510.158.8748439.42210682CS
12-3.665-28.030592734213.07515.228.87467011.28681145CS
26-4.95-34.470752089114.3619.28.874130113.65933659CS
522.8743.88379204896.5419.26.34119113.59904985CS
1565.04115.331807784.3719.21.9921386.29569286CS
260-10.79-53.415841584220.220.21.9920087.20193636CS

DNPUF - Frequently Asked Questions (FAQ)

What is the current Dai Nippon Pharmaceutical (PK) share price?
The current share price of Dai Nippon Pharmaceutical (PK) is US$ 9,41
How many Dai Nippon Pharmaceutical (PK) shares are in issue?
Dai Nippon Pharmaceutical (PK) has 448.593.449 shares in issue
What is the market cap of Dai Nippon Pharmaceutical (PK)?
The market capitalisation of Dai Nippon Pharmaceutical (PK) is USD 4,22B
What is the 1 year trading range for Dai Nippon Pharmaceutical (PK) share price?
Dai Nippon Pharmaceutical (PK) has traded in the range of US$ 6,34 to US$ 19,20 during the past year
What is the PE ratio of Dai Nippon Pharmaceutical (PK)?
The price to earnings ratio of Dai Nippon Pharmaceutical (PK) is 5,27
What is the cash to sales ratio of Dai Nippon Pharmaceutical (PK)?
The cash to sales ratio of Dai Nippon Pharmaceutical (PK) is 1,4
What is the registered address of Dai Nippon Pharmaceutical (PK)?
The registered address for Dai Nippon Pharmaceutical (PK) is 6-8, Doshomachi 2-chome, Osaka, 541-0045
What is the Dai Nippon Pharmaceutical (PK) website address?
The website address for Dai Nippon Pharmaceutical (PK) is www.sumitomo-pharma.com
Which industry sector does Dai Nippon Pharmaceutical (PK) operate in?
Dai Nippon Pharmaceutical (PK) operates in the Pharmaceuticals sector

DNPUF Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen